John R. Pinion II
2016
In 2016, John R. Pinion II earned a total compensation of $2M as Chief Quality Operations Officer and Executive Vice President Analytical Sciences and Research at Ultragenyx Pharmaceutical, a 74% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $167,658 |
|---|---|
| Option Awards | $1,222,295 |
| Salary | $399,185 |
| Stock Awards | $211,710 |
| Other | $34,614 |
| Total | $2,035,462 |
Pinion received $1.2M in option awards, accounting for 60% of the total pay in 2016.
Pinion also received $167.7K in non-equity incentive plan, $399.2K in salary, $211.7K in stock awards and $34.6K in other compensation.
Rankings
In 2016, John R. Pinion II's compensation ranked 4,810th out of 14,075 executives tracked by ExecPay. In other words, Pinion earned more than 65.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,810 out of 14,075 | 66th |
Division Manufacturing | 1,712 out of 5,486 | 69th |
Major group Chemicals And Allied Products | 532 out of 1,900 | 72nd |
Industry group Drugs | 392 out of 1,543 | 75th |
Industry Pharmaceutical Preparations | 310 out of 1,173 | 74th |
Source: SEC filing on April 28, 2017.
Pinion's colleagues
We found five more compensation records of executives who worked with John R. Pinion II at Ultragenyx Pharmaceutical in 2016.
2016
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2016
Karah Parschauer
Ultragenyx Pharmaceutical
General Counsel
2016
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
2016
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2016
Thomas Kassberg
Ultragenyx Pharmaceutical